All M&A articles

  • markus-winkler-IrRbSND5EUc-unsplash
    Article

    The European eyecare sector remains an attractive M&A market

    2026-01-26T06:22:00Z

    There were 28 company transactions – including full takeovers and acquisitions of minority stakes – in the eyecare and eyewear sector in Europe in 2025, according to a recent report by Houlihan Lokey, a global investment bank monitoring the sector and other consumer markets. The company was involved last year ...

  • News briefs

    VSP Vision completes Marcolin’s acquisition

    2026-01-07T08:07:00Z

    VSP Vision announced on Dec. 23, 2025 that it has completed the acquisition of Italian eyewear group Marcolin from PAI Partners, which held a 78 percent stake in the company since 2012, and other minority shareholders. The combination of Marchon Eyewear, the eyewear unit of VSP Vision, and Marcolin gives ...

  • News briefs

    STAAR shareholders reject Alcon merger agreement

    2026-01-07T08:07:00Z

    The shareholders of STAAR Surgical, a California-based refractive surgery company that specializes in Implantable Collamer Lenses (ICLs), voted against the proposed merger agreement with Alcon yesterday. The agreement, which was contested from the start by Broadwood Partners and other key investors in the company, was recently upgraded in price to ...

  • Safilo
    Article

    Seeing a 'strategic opportunity,' Safilo builds up a 25% stake in Inspecs

    2026-01-05T04:34:00Z

    On Dec. 15, 2025, Safilo officially announced that it did not intend to make a firm offer for the acquisition of Inspecs. The announcement followed Inspecs’ statement on Dec. 10, 2025, that the board had found an agreement with Bidco for an 84 pence (€0.96) per share deal that values ...

  • Lentilles Moins Chères
    Article

    Vision Group acquires LMC/Sensee

    2025-12-19T09:13:00Z

    Group Héron, the French retail group, is selling the entirety of LMC/Sensee to Vision Group, a Swiss specialist in contact lenses. The financial terms of the sale have not been disclosed. The executive staff at LMC/Sensee is “fully involved in the decision” and will be remaining in place to manage ...

  • News briefs

    EssilorLuxottica acquires another ophthalmology clinics group

    2025-12-12T09:28:00Z

    EssilorLuxottica is set to acquire Signifeye, a prominent Belgian ophthalmology platform, the group has announced. This acquisition adds to the group’s growing presence in ophthalmology clinics, with Signifeye operating 15 eye centers in the Flanders region. The move follows the recent acquisition of Optegra, which manages over 70 clinics across ...

  • News briefs

    Alcon upgraded bid for STAAR Surgical still contested

    2025-12-12T07:29:00Z

    Alcon has upped its offer to acquire STAAR Surgical, a California-based refractive surgery company that specializes in Implantable Collamer Lenses (ICLs), the company announced on Dec. 9, 2025. The newly agreed price of $30.75 per share, up from $28 in the initial agreement, values the target company at approximately $1.6 ...

  • Inspecs logo
    Article

    Inspecs board accepts £85m takeover by two British entrepreneurs

    2025-12-11T08:12:00Z

    Inspecs Group’s board has agreed to an £85 million acquisition by two British entrepreneurs Luke Johnson and Ian Livingstone, formerly majority owner and chairman of Optika Clulow, after rejecting offers from Safilo Group.  

  • Inspecs
    Article

    Inspecs takeover talks extended with current highest bid at £85m

    2025-11-22T01:24:00Z

    Private equity seems to have an edge in the negotiations but Safilo is reviewing its options. The UK-based eyewear group has also announced a trading update that forecasts a 4 percent decline in annual revenue. 

  • Paris Miki
    Article

    Paris Miki main stakeholder to delist the company through an MBO

    2025-11-17T12:24:00Z

    The tender offer by the founding family fund values the company at approximately 33 billion yen (€182m). The plan is to restructure the retailer’s domestic and overseas businesses after a decade of revenue stagnation and low or negative profit margins. 

  • Alcon
    Article

    Alcon Q3 CL sales grow 6%, sees STAAR deal as attractive but not essential

    2025-11-14T01:11:00Z

    Alcon generated $707 million in contact lens sales in the third quarter ended Sept. 30, up by 6 percent compared to the year earlier, as growth was driven by product innovation and price increases, partially offset by declines in legacy products. At constant-currency rates, sales were up by 5 percent. ...

  • News briefs

    Alcon and STAAR Surgical amend merger agreement

    2025-11-10T08:42:00Z

    STAAR Surgical has announced the amendment of its agreement for its acquisition by Alcon, which has been criticized by Broadwood Partners and other shareholders in the California-based refractive surgery company since the initial announcement in August. Among other things, the new agreement allows STAAR Surgical to solicit other third-party bids ...

  • Inspecs
    Article

    Investor pressures Inspecs for sum-of-the-parts deal

    2025-10-30T10:18:00Z

    First Seagull, a Norwegian investor holding a 5.5 percent stake in Inspecs Group, is pressing the UK-based eyewear group to prioritize a sum-of-the-parts divestment of its business in a letter sent to the company’s board on Oct. 24. The move follows the announcement by Inspecs last week that it had ...

  • Inspecs
    Article

    Private equity firms look at Inspecs takeover, Safilo too but only for some assets

    2025-10-24T12:02:00Z

    Inspecs Group confirmed yesterday press reports about two separate unsolicited proposals from private equity firms, “each setting out non-binding possible cash offers alongside the possibility of an alternative offer including unlisted securities to acquire the entire issued and to be issued share capital of Inspecs.” Inspecs stock price takes off ...

  • News briefs

    Topcon acquires Toku

    2025-10-21T10:18:00Z

    Topcon Healthcare is adding one more brick to its Healthcare from the Eye program with the acquisition of Toku, a San Diego-based AI health-tech company that originated in New Zealand. Topcon, along with US retail group National Vision, already led an $8 million Series A investment round in Toku in ...

  • News briefs

    EssilorLuxottica reinforces AI and medtech expertise with new acquisition

    2025-10-17T08:51:00Z

    EssilorLuxottica announced its seventh M&A operation this year with the acquisition of Ikerian, a Swiss-based medtech startup founded in 1990 and operating under the RetinAI brand that will further reinforce the group’s medtech offering. RetinAI’s area of expertise is artificial intelligence (AI) and data management in eye care. It develops ...

  • News briefs

    Design Eyewear Group acquires six brands from French company KNCO

    2025-10-13T13:18:00Z

    Design Eyewear Group has acquired six brands from French eyewear company KNCO, marking its entry into children’s eyewear and doubling its portfolio to 20 brands in recent months.

  • 250105_JS_FIELMANN_07_MOTIV_112 1
    Article

    ZEISS Vision Care invests in Fielmann-owned teleophthalmology platform

    2025-10-02T08:52:00Z

    ZEISS Vision Care is taking a 10 percent stake in Ocumeda, the tele-ophthalmology platform owned by Fielmann Group, with plans to acquire up to a 25 percent stake, the company has announced. The transaction values Ocumeda at €100 million. Founded in 2019 and led by a team of ophthalmologists, Ocumeda ...

  • IXI-engingeering (1)
    Article

    IXI ramps up autofocus glasses supply chain

    2025-10-01T07:24:00Z

    IXI, the Finnish-based start-up developing autofocus glasses, has announced two major initiatives meant to accelerate its development and prepare for the commercial launch of its product. As previously reported, the company raised $36 million from private equity firms and Amazon Alexa Fund among others earlier this year. ...

  • Topcon-größer_woiweb
    Article

    Topcon Healthcare steps into mental health diagnosis with new investment

    2025-09-10T09:04:00Z

    Topcon Healthcare is making a strategic investment in Senseye, a US-based start-up “developing the first mental health diagnostic platform powered by ocular biomarkers,” according to the official statement. “Topcon Healthcare’s investment is more than capital, it is validation from a global leader in digital health technology that the eye holds ...